ArticleCureus2026
Nicotine Pouch Patterns of Use in a 10-Week Prospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNicotine pouch (NP) product use has increased in the US, but limited data are available on how NPs are used and if they affect the use of other tobacco and/or nicotine products (TNPs), specifically transition away from more harmful TNPs such as cigarettes.
methodsThis prospective, observational study gathered information on daily use patterns of combustible and non-combustible TNPs (cigarettes, cigars, pipe tobacco, hookah, e-cigarettes, oral smokeless tobacco (ST)) and reasons for use among current adult NP users (n=346, ≥18 years old during the 2017-2018 study period) recruited with canister stickers in the 11 states where
resultsThe proportion of participants who used NP-Z and smoked cigarettes at least one day a week at baseline decreased from 15.9% (12.0-19.8%) to 8.1% (5.2-11.0%) over the study period. Nearly half of them stopped smoking by week 10 (8.1% (5.2-11.0%) to 4.9% (2.6-7.2%)). Among those who used NP-Z and moist snuff, use of the latter declined from 15.0% (11.2-18.8%) to 7.5% (4.7-10.3%). Overall, 24.0% (19.5-28.5%) of participants who used NP-Z and other TNPs at baseline reported exclusive NP-Z use by the end of the 10-week study.
conclusionPatterns of use among early NP-Z adopters indicate that NPs can be acceptable replacements for other TNPs, particularly cigarettes and oral ST.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.